Dihydroetorphine-induced place preference was mediated by dopamine D1 receptors in rats

Acta Pharmacologica Sinica

Volumn 20, Issue 4, 1999, Pages 381-384

  Liu, Zhong Hua ^a,b   Zhang, Kai Gao ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b BINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Animal behavior; Dihydroetorphine; Dopamine D1 receptors; Dopamine D2 receptors; Haloperidol; Nucleus accumbens; Psychological adaptation; Sch 23390; Spiperone; Sulpiride

Indexed keywords

8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; DIHYDROETORPHINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; HALOPERIDOL; SODIUM CHLORIDE; SPIPERONE; SULPIRIDE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOPAMINE RECEPTOR BLOCKING; DOPAMINERGIC SYSTEM; DRUG ANTAGONISM; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; INTRAPERITONEAL DRUG ADMINISTRATION; MICROINJECTION; NONHUMAN; PLACE PREFERENCE; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; ANIMALS; BEHAVIOR, ANIMAL; DOPAMINE AGONISTS; ETORPHINE; HALOPERIDOL; MALE; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; SPIPERONE; SULPIRIDE;

EID: 0032964607     PISSN: 02539756     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Katz RJ. Gormenzano GA. A rapid and inexpensive technique for assessing the reinforcing effects of opiate drugs. Pharmacol Biochem Behav 1979; 11: 231-3.
2. Shippenberg TS, Herz A. Motivational effects of opioids: influence of D-1 versus D-2 receptor antagonists. Eur J Pharmacol 1988; 151: 233-42.
3. Van der Kooy D, Mucha RF, O'Shaughnessy M, Bucenieks P. Reinforcing properties of brain microinjections of morphine revealed by conditioned place preference. Brain Res 1982; 243: 107-17.
4. Shippenberg TS, Bals-Kubik R, Herz A. Examination of the neurochemical substrates mediating the motivational effects of opioids: role of the mesolimbic dopamine system and D-1 vs D-2 dopamine receptors. J Pharmacol Exp Ther 1993; 265: 53-9.
5. Spyraki C, Fibiger HC, Phillips AG. Attenuation of heroin reward in rats by disruption of the mesolimbic dopamine system. Psychopharmacology 1983; 79: 278-83.
6. Di Chiara G, Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 1988; 85: 5274-8.
7. Wang DX, Huang M, Qin BY. Binding characteristics of DHE to opioid receptors in rat brain. Chin J Pharmacol Toxicol 1991; 5: 161-3.
8. Wang NS, Deng HB, Cai ZJ. Dihydroetorphine in conditioned place preference. Chin Bull Drug Depend 1993; 2: 271-3.
9. Paxions G, Watson C, editers. The rat brain in stereotaxic coordinates. London: Academic Press; 1986.
10. Ren YH, Liu ZH, Zhang KG. Conditioned place preference experiment controlled by microcomputer. Chin Bull Drug Depend 1997; 6: 26-9.
11. 3H-SCH23390, a selective D-1 receptor antagonist ligand, in rat striatum. Life Sci 1984; 35: 1885-93.
12. 2) receptors. Eur J Pharmacol 1986; 129: 369-70.
13. O'Connor SE, Brown RA. The pharmacology of sulpiride-a dopamine receptor antagonist. Gen Pharmacol 1982; 13: 185-98.
14. 2 receptors. Nature 1997; 388: 586-9.
15. Bardo MT. Neuropharmacological mechanisms of drug reward: beyond dopamine in the nucleus accumbens. Crit Rev Neurobiol 1998; 12: 37-67.